DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Kerr RS. et al.
Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial.

Lancet Oncol 2016;
17: 1543-1557

Download Bibliographical Data

Search in:
Access: